

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.25713105 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.25713105 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.09540327 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.89560946 |
| 5 | detection of bacterium (GO:0016045) | 3.83182619 |
| 6 | detection of other organism (GO:0098543) | 3.80246930 |
| 7 | regulation of mast cell degranulation (GO:0043304) | 3.72614710 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.54223042 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52103209 |
| 10 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.44158568 |
| 11 | neutrophil activation (GO:0042119) | 3.39913915 |
| 12 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.33329384 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 3.29219770 |
| 14 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.28512906 |
| 15 | regulation of leukocyte degranulation (GO:0043300) | 3.26744877 |
| 16 | granulocyte activation (GO:0036230) | 3.24104746 |
| 17 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.22698749 |
| 18 | respiratory burst (GO:0045730) | 3.15569768 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 3.13646513 |
| 20 | mannose metabolic process (GO:0006013) | 3.12980669 |
| 21 | sodium ion export (GO:0071436) | 3.10600028 |
| 22 | detection of external biotic stimulus (GO:0098581) | 3.08614270 |
| 23 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.07743701 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.04398845 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.04398845 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.04398845 |
| 27 | positive regulation by symbiont of host defense response (GO:0052509) | 3.04398845 |
| 28 | modulation by symbiont of host defense response (GO:0052031) | 3.04398845 |
| 29 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04398845 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.04361962 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.04361962 |
| 32 | positive thymic T cell selection (GO:0045059) | 3.03842310 |
| 33 | negative regulation of innate immune response (GO:0045824) | 3.02020627 |
| 34 | response to muramyl dipeptide (GO:0032495) | 2.97518013 |
| 35 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.97416165 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95738266 |
| 37 | adenosine receptor signaling pathway (GO:0001973) | 2.94238107 |
| 38 | macrophage activation involved in immune response (GO:0002281) | 2.93724800 |
| 39 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.93169254 |
| 40 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.92280453 |
| 41 | regulation of mast cell activation (GO:0033003) | 2.92065119 |
| 42 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.91811360 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89963142 |
| 44 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.88748116 |
| 45 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.86997500 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.85210306 |
| 47 | lipoxygenase pathway (GO:0019372) | 2.84651345 |
| 48 | positive regulation of B cell differentiation (GO:0045579) | 2.78944951 |
| 49 | B cell mediated immunity (GO:0019724) | 2.77887621 |
| 50 | modulation by virus of host process (GO:0019054) | 2.77431701 |
| 51 | germinal center formation (GO:0002467) | 2.74148100 |
| 52 | cellular potassium ion homeostasis (GO:0030007) | 2.73628978 |
| 53 | detection of biotic stimulus (GO:0009595) | 2.71048453 |
| 54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.69520765 |
| 55 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67195053 |
| 56 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.65549574 |
| 57 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.63944336 |
| 58 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.63944336 |
| 59 | negative thymic T cell selection (GO:0045060) | 2.63402933 |
| 60 | regulation of superoxide anion generation (GO:0032928) | 2.63231414 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.63201797 |
| 62 | regulation of regulated secretory pathway (GO:1903305) | 2.62747863 |
| 63 | type I interferon signaling pathway (GO:0060337) | 2.61009056 |
| 64 | cellular response to type I interferon (GO:0071357) | 2.61009056 |
| 65 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.60556410 |
| 66 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.60556410 |
| 67 | modulation by symbiont of host cellular process (GO:0044068) | 2.60256738 |
| 68 | regulation of gamma-delta T cell activation (GO:0046643) | 2.59461478 |
| 69 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.59151830 |
| 70 | positive regulation of mast cell degranulation (GO:0043306) | 2.58058549 |
| 71 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.58058549 |
| 72 | response to type I interferon (GO:0034340) | 2.57965612 |
| 73 | defense response to protozoan (GO:0042832) | 2.57581035 |
| 74 | amyloid precursor protein catabolic process (GO:0042987) | 2.56473805 |
| 75 | synaptic vesicle maturation (GO:0016188) | 2.56172219 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.55922337 |
| 77 | thymic T cell selection (GO:0045061) | 2.55518725 |
| 78 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.55390558 |
| 79 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54622544 |
| 80 | negative regulation of T cell mediated immunity (GO:0002710) | 2.53670686 |
| 81 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.52789548 |
| 82 | leukocyte aggregation (GO:0070486) | 2.51161169 |
| 83 | positive regulation of lamellipodium assembly (GO:0010592) | 2.50935120 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50226038 |
| 85 | regulation of early endosome to late endosome transport (GO:2000641) | 2.49883474 |
| 86 | neutrophil mediated immunity (GO:0002446) | 2.49583285 |
| 87 | pentose-phosphate shunt (GO:0006098) | 2.49283661 |
| 88 | detection of molecule of bacterial origin (GO:0032490) | 2.48682420 |
| 89 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.47344165 |
| 90 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.47344165 |
| 91 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.46225396 |
| 92 | tolerance induction (GO:0002507) | 2.45561622 |
| 93 | myeloid cell activation involved in immune response (GO:0002275) | 2.44749598 |
| 94 | regulation of platelet aggregation (GO:0090330) | 2.44375023 |
| 95 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.43777327 |
| 96 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.43460378 |
| 97 | pinocytosis (GO:0006907) | 2.43182454 |
| 98 | negative T cell selection (GO:0043383) | 2.43178867 |
| 99 | regulation of ARF protein signal transduction (GO:0032012) | 2.42620070 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.41759502 |
| 101 | low-density lipoprotein particle clearance (GO:0034383) | 2.41471260 |
| 102 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.41117951 |
| 103 | cellular extravasation (GO:0045123) | 2.39267725 |
| 104 | negative regulation of interleukin-17 production (GO:0032700) | 2.39014011 |
| 105 | cellular response to zinc ion (GO:0071294) | 2.36333820 |
| 106 | natural killer cell differentiation (GO:0001779) | 2.36063892 |
| 107 | immunoglobulin mediated immune response (GO:0016064) | 2.35114739 |
| 108 | NIK/NF-kappaB signaling (GO:0038061) | 2.33758654 |
| 109 | positive regulation of p38MAPK cascade (GO:1900745) | 2.30651783 |
| 110 | response to protozoan (GO:0001562) | 2.29503019 |
| 111 | regulation of B cell differentiation (GO:0045577) | 2.28371990 |
| 112 | barbed-end actin filament capping (GO:0051016) | 2.27215128 |
| 113 | mature B cell differentiation (GO:0002335) | 2.25821986 |
| 114 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.23152008 |
| 115 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.23071059 |
| 116 | response to host (GO:0075136) | 2.23071059 |
| 117 | response to host defenses (GO:0052200) | 2.23071059 |
| 118 | regulation of natural killer cell differentiation (GO:0032823) | 2.22146339 |
| 119 | synaptic vesicle exocytosis (GO:0016079) | 2.22091256 |
| 120 | response to host immune response (GO:0052572) | 2.21335665 |
| 121 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.21335665 |
| 122 | activation of MAPKKK activity (GO:0000185) | 2.21281416 |
| 123 | oxaloacetate metabolic process (GO:0006107) | 2.20415518 |
| 124 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.18979632 |
| 125 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.17457298 |
| 126 | response to nerve growth factor (GO:1990089) | 2.15572255 |
| 127 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.15572255 |
| 128 | actin filament polymerization (GO:0030041) | 2.14835750 |
| 129 | NADPH regeneration (GO:0006740) | 2.14649948 |
| 130 | response to peptidoglycan (GO:0032494) | 2.14464337 |
| 131 | leukocyte degranulation (GO:0043299) | 2.12907636 |
| 132 | positive regulation of antigen processing and presentation (GO:0002579) | 2.12108405 |
| 133 | regulation of synaptic vesicle transport (GO:1902803) | 2.10057482 |
| 134 | creatine metabolic process (GO:0006600) | 2.09532388 |
| 135 | leukocyte mediated cytotoxicity (GO:0001909) | 2.08045844 |
| 136 | positive regulation of mast cell activation (GO:0033005) | 2.06821729 |
| 137 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.06443830 |
| 138 | mature B cell differentiation involved in immune response (GO:0002313) | 2.05718038 |
| 139 | phagosome maturation (GO:0090382) | 2.05703419 |
| 140 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.05537734 |
| 141 | regulation of synapse structural plasticity (GO:0051823) | 2.04914526 |
| 142 | response to acidic pH (GO:0010447) | 2.04178316 |
| 143 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.03906770 |
| 144 | negative regulation of type 2 immune response (GO:0002829) | 2.03748854 |
| 145 | myeloid dendritic cell differentiation (GO:0043011) | 2.03478527 |
| 146 | Peyers patch development (GO:0048541) | 2.02922153 |
| 147 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.02922153 |
| 148 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.02507931 |
| 149 | regulation of chemokine biosynthetic process (GO:0045073) | 2.02185374 |
| 150 | B cell receptor signaling pathway (GO:0050853) | 2.02094898 |
| 151 | regulation of ARF GTPase activity (GO:0032312) | 2.01598611 |
| 152 | mast cell activation (GO:0045576) | 2.01597663 |
| 153 | myeloid leukocyte mediated immunity (GO:0002444) | 2.01336312 |
| 154 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.01287577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.63773726 |
| 2 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60297382 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.41947254 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39494032 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.38410447 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.38196758 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.33764465 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.33007419 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.29831367 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.28344426 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26616973 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.24796212 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.22254660 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20020710 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19743309 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.12573058 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.11958609 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10792166 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08436452 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02073940 |
| 21 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.01867564 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 1.91499781 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.88769482 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88657030 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.87870233 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87059873 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86752939 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.85901853 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82050670 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.81940380 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79990828 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79114556 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75117415 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74090371 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66563965 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65964508 |
| 37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.62238162 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.59177515 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57800242 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53927461 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52837823 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49932207 |
| 43 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48446884 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48052462 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47946929 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47932843 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45932277 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.44904146 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44170269 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.43950531 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42322887 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41225638 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40136271 |
| 54 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.39605292 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38488420 |
| 56 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.38294455 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34859569 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34648430 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33377158 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.32955413 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32424668 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32408921 |
| 63 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.32336685 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32146967 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31272672 |
| 66 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30754328 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30478050 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30293789 |
| 69 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30150473 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29071204 |
| 71 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28956097 |
| 72 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.28922143 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27551771 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26976119 |
| 75 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.26896205 |
| 76 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.26521714 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.26302913 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26027986 |
| 79 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25788094 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25570050 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25449450 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25202790 |
| 83 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25170345 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24451158 |
| 85 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24426727 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24118774 |
| 87 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23788933 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23617020 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23341138 |
| 90 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22859284 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 1.22505290 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21283246 |
| 93 | MYB_26560356_Chip-Seq_TH2_Human | 1.19993762 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.19727586 |
| 95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19629523 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.19002030 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18205451 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15695117 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15133632 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15006574 |
| 101 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14775514 |
| 102 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.14726200 |
| 103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13817048 |
| 104 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.13123318 |
| 105 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13022927 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12293948 |
| 107 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.11798400 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11575726 |
| 109 | P68_20966046_ChIP-Seq_HELA_Human | 1.11555257 |
| 110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07734080 |
| 111 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.07696562 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07485358 |
| 113 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07469289 |
| 114 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07380543 |
| 115 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07246583 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06931852 |
| 117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06046574 |
| 118 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05917312 |
| 119 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05377615 |
| 120 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.04946466 |
| 121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04624194 |
| 122 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03834608 |
| 123 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03781908 |
| 124 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03766788 |
| 125 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03278064 |
| 126 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01542493 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00262499 |
| 128 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00240305 |
| 129 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99771649 |
| 130 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98007885 |
| 131 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97084908 |
| 132 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96778544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 4.30128864 |
| 2 | MP0003303_peritoneal_inflammation | 3.28380118 |
| 3 | MP0005451_abnormal_body_composition | 3.14604741 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.75370632 |
| 5 | MP0003436_decreased_susceptibility_to | 2.69630937 |
| 6 | MP0009840_abnormal_foam_cell | 2.62449147 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.49462761 |
| 8 | MP0008260_abnormal_autophagy | 2.49232519 |
| 9 | MP0000465_gastrointestinal_hemorrhage | 2.41621896 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 2.29153847 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.28483939 |
| 12 | MP0003075_altered_response_to | 2.19234614 |
| 13 | MP0000685_abnormal_immune_system | 2.14552287 |
| 14 | MP0009785_altered_susceptibility_to | 2.14134717 |
| 15 | MP0003329_amyloid_beta_deposits | 2.11450894 |
| 16 | MP0000604_amyloidosis | 2.00897385 |
| 17 | MP0004858_abnormal_nervous_system | 2.00705424 |
| 18 | MP0002419_abnormal_innate_immunity | 1.95110654 |
| 19 | MP0005464_abnormal_platelet_physiology | 1.87988463 |
| 20 | MP0005000_abnormal_immune_tolerance | 1.87972515 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 1.86959056 |
| 22 | MP0005025_abnormal_response_to | 1.86796581 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.83612946 |
| 24 | MP0009278_abnormal_bone_marrow | 1.77384005 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.64108738 |
| 26 | MP0001800_abnormal_humoral_immune | 1.59605303 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.59554880 |
| 28 | MP0005387_immune_system_phenotype | 1.56506697 |
| 29 | MP0001790_abnormal_immune_system | 1.56506697 |
| 30 | MP0002723_abnormal_immune_serum | 1.56237448 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.55006107 |
| 32 | MP0005671_abnormal_response_to | 1.51877166 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.51102342 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.51008321 |
| 35 | MP0003724_increased_susceptibility_to | 1.50457287 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.48233339 |
| 37 | MP0004947_skin_inflammation | 1.47589137 |
| 38 | MP0004130_abnormal_muscle_cell | 1.47490310 |
| 39 | MP0001819_abnormal_immune_cell | 1.46047871 |
| 40 | MP0002132_abnormal_respiratory_system | 1.45597951 |
| 41 | MP0002254_reproductive_system_inflammat | 1.44623939 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.44149802 |
| 43 | MP0008004_abnormal_stomach_pH | 1.42037970 |
| 44 | MP0005310_abnormal_salivary_gland | 1.41764491 |
| 45 | MP0005166_decreased_susceptibility_to | 1.39434632 |
| 46 | MP0003828_pulmonary_edema | 1.38987898 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.38874217 |
| 48 | MP0005083_abnormal_biliary_tract | 1.36985655 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.35617579 |
| 50 | MP0006082_CNS_inflammation | 1.33999594 |
| 51 | MP0000751_myopathy | 1.32247423 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.30938825 |
| 53 | MP0000747_muscle_weakness | 1.30774871 |
| 54 | MP0000749_muscle_degeneration | 1.27600721 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.27498206 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.27498206 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.27060939 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.26564475 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.25752217 |
| 60 | MP0009764_decreased_sensitivity_to | 1.24591159 |
| 61 | MP0001873_stomach_inflammation | 1.24269883 |
| 62 | MP0000343_altered_response_to | 1.24023705 |
| 63 | MP0002909_abnormal_adrenal_gland | 1.22662215 |
| 64 | MP0001968_abnormal_touch/_nociception | 1.20118773 |
| 65 | MP0002736_abnormal_nociception_after | 1.17038105 |
| 66 | MP0003635_abnormal_synaptic_transmissio | 1.16296879 |
| 67 | MP0003279_aneurysm | 1.16061239 |
| 68 | MP0001853_heart_inflammation | 1.14415118 |
| 69 | MP0004270_analgesia | 1.12954107 |
| 70 | MP0000490_abnormal_crypts_of | 1.11189207 |
| 71 | MP0008469_abnormal_protein_level | 1.10470460 |
| 72 | MP0003866_abnormal_defecation | 1.09702092 |
| 73 | MP0002006_tumorigenesis | 1.09232474 |
| 74 | MP0000858_altered_metastatic_potential | 1.09063458 |
| 75 | MP0008874_decreased_physiological_sensi | 1.08587632 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.07431427 |
| 77 | MP0005535_abnormal_body_temperature | 1.06960156 |
| 78 | MP0008961_abnormal_basal_metabolism | 1.06310341 |
| 79 | MP0000716_abnormal_immune_system | 1.05236633 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 1.03333695 |
| 81 | MP0000015_abnormal_ear_pigmentation | 1.02459968 |
| 82 | MP0002405_respiratory_system_inflammati | 1.02350985 |
| 83 | MP0001348_abnormal_lacrimal_gland | 1.02089931 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.98957195 |
| 85 | MP0002398_abnormal_bone_marrow | 0.98819124 |
| 86 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97656493 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.97219293 |
| 88 | MP0004381_abnormal_hair_follicle | 0.96662303 |
| 89 | MP0010155_abnormal_intestine_physiology | 0.96364796 |
| 90 | MP0002064_seizures | 0.95369109 |
| 91 | MP0003633_abnormal_nervous_system | 0.95257085 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.95152115 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.93273604 |
| 94 | MP0001663_abnormal_digestive_system | 0.93039212 |
| 95 | MP0002735_abnormal_chemical_nociception | 0.92285776 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.88586848 |
| 97 | MP0009763_increased_sensitivity_to | 0.86105877 |
| 98 | MP0003646_muscle_fatigue | 0.85951392 |
| 99 | MP0005330_cardiomyopathy | 0.85604165 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.85511329 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.85473310 |
| 102 | MP0000689_abnormal_spleen_morphology | 0.83632203 |
| 103 | MP0001970_abnormal_pain_threshold | 0.83051859 |
| 104 | MP0002998_abnormal_bone_remodeling | 0.81956954 |
| 105 | MP0002429_abnormal_blood_cell | 0.81601697 |
| 106 | MP0005501_abnormal_skin_physiology | 0.81287957 |
| 107 | MP0004036_abnormal_muscle_relaxation | 0.81191908 |
| 108 | MP0006036_abnormal_mitochondrial_physio | 0.80892276 |
| 109 | MP0003879_abnormal_hair_cell | 0.78709638 |
| 110 | MP0003448_altered_tumor_morphology | 0.77603403 |
| 111 | MP0004087_abnormal_muscle_fiber | 0.77241567 |
| 112 | MP0002722_abnormal_immune_system | 0.77129606 |
| 113 | MP0002063_abnormal_learning/memory/cond | 0.76716660 |
| 114 | MP0000920_abnormal_myelination | 0.76628300 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.75834436 |
| 116 | MP0000249_abnormal_blood_vessel | 0.75753893 |
| 117 | MP0004185_abnormal_adipocyte_glucose | 0.73919359 |
| 118 | MP0003690_abnormal_glial_cell | 0.73287355 |
| 119 | MP0005390_skeleton_phenotype | 0.72907795 |
| 120 | MP0000750_abnormal_muscle_regeneration | 0.71827060 |
| 121 | MP0002106_abnormal_muscle_physiology | 0.71717744 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.71715028 |
| 123 | MP0001851_eye_inflammation | 0.71652332 |
| 124 | MP0002796_impaired_skin_barrier | 0.71470462 |
| 125 | MP0005165_increased_susceptibility_to | 0.67703732 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.67701250 |
| 127 | MP0005381_digestive/alimentary_phenotyp | 0.65084789 |
| 128 | MP0000678_abnormal_parathyroid_gland | 0.64565038 |
| 129 | MP0002019_abnormal_tumor_incidence | 0.63991106 |
| 130 | MP0001986_abnormal_taste_sensitivity | 0.63989019 |
| 131 | MP0003795_abnormal_bone_structure | 0.63141638 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.62852260 |
| 133 | MP0009931_abnormal_skin_appearance | 0.61671980 |
| 134 | MP0002277_abnormal_respiratory_mucosa | 0.59506004 |
| 135 | MP0002933_joint_inflammation | 0.59331010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Purpura (HP:0000979) | 4.35462273 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.05131301 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.82052461 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.76280674 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 3.34487191 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.12393210 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.11037281 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.09423138 |
| 9 | Abnormal platelet volume (HP:0011876) | 3.03917383 |
| 10 | Abnormality of macrophages (HP:0004311) | 2.96039362 |
| 11 | Asymmetric septal hypertrophy (HP:0001670) | 2.95405182 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.90662365 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 2.89023548 |
| 14 | Hepatosplenomegaly (HP:0001433) | 2.86901479 |
| 15 | Dysostosis multiplex (HP:0000943) | 2.80087987 |
| 16 | Chronic otitis media (HP:0000389) | 2.78450953 |
| 17 | Nasal polyposis (HP:0100582) | 2.78269741 |
| 18 | Axonal loss (HP:0003447) | 2.75216736 |
| 19 | Myositis (HP:0100614) | 2.73661029 |
| 20 | Menorrhagia (HP:0000132) | 2.70829867 |
| 21 | Chest pain (HP:0100749) | 2.63419595 |
| 22 | Visual hallucinations (HP:0002367) | 2.60195091 |
| 23 | Encephalitis (HP:0002383) | 2.58500967 |
| 24 | Interstitial pulmonary disease (HP:0006530) | 2.56712587 |
| 25 | Hypertensive crisis (HP:0100735) | 2.56349304 |
| 26 | Increased IgM level (HP:0003496) | 2.56253228 |
| 27 | Cellulitis (HP:0100658) | 2.56064682 |
| 28 | Hypercortisolism (HP:0001578) | 2.55948425 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 2.55157211 |
| 30 | Increased mean platelet volume (HP:0011877) | 2.53622625 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.48770791 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.48770791 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 2.48323353 |
| 34 | Neurofibrillary tangles (HP:0002185) | 2.47265539 |
| 35 | Recurrent skin infections (HP:0001581) | 2.44518833 |
| 36 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.44344271 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.41425969 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.41425969 |
| 39 | Loss of speech (HP:0002371) | 2.40460393 |
| 40 | Achilles tendon contracture (HP:0001771) | 2.39788365 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.38590903 |
| 42 | Myokymia (HP:0002411) | 2.36814400 |
| 43 | Ragged-red muscle fibers (HP:0003200) | 2.35448555 |
| 44 | Abnormality of the Achilles tendon (HP:0005109) | 2.30108253 |
| 45 | Retrobulbar optic neuritis (HP:0100654) | 2.29624011 |
| 46 | Optic neuritis (HP:0100653) | 2.29624011 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.28234531 |
| 48 | Abnormality of iron homeostasis (HP:0011031) | 2.28095864 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27477505 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27477505 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27477505 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.26607047 |
| 53 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26203520 |
| 54 | Gastrointestinal stroma tumor (HP:0100723) | 2.24131849 |
| 55 | Urticaria (HP:0001025) | 2.23041502 |
| 56 | Gingivitis (HP:0000230) | 2.23004949 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18551196 |
| 58 | Obstructive lung disease (HP:0006536) | 2.18551196 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.18299206 |
| 60 | Peritonitis (HP:0002586) | 2.17098317 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.16405433 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.14264189 |
| 63 | Orchitis (HP:0100796) | 2.13101677 |
| 64 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.10416285 |
| 65 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.10416285 |
| 66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.10416285 |
| 67 | Amyloidosis (HP:0011034) | 2.07600150 |
| 68 | Bulbar palsy (HP:0001283) | 2.07225298 |
| 69 | Cerebral hemorrhage (HP:0001342) | 2.06731469 |
| 70 | Granulocytopenia (HP:0001913) | 2.06306745 |
| 71 | Tetraparesis (HP:0002273) | 2.05932601 |
| 72 | Distal lower limb muscle weakness (HP:0009053) | 2.05231068 |
| 73 | Petechiae (HP:0000967) | 2.05182224 |
| 74 | Gastrointestinal inflammation (HP:0004386) | 2.05153850 |
| 75 | Inflammation of the large intestine (HP:0002037) | 2.03284044 |
| 76 | Arterial thrombosis (HP:0004420) | 2.03047722 |
| 77 | Exercise-induced myalgia (HP:0003738) | 2.02710466 |
| 78 | Rapidly progressive (HP:0003678) | 2.02676976 |
| 79 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.02417313 |
| 80 | Progressive neurologic deterioration (HP:0002344) | 2.02103151 |
| 81 | Polycythemia (HP:0001901) | 2.00857931 |
| 82 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99388690 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 1.98066455 |
| 84 | Hypertriglyceridemia (HP:0002155) | 1.96243297 |
| 85 | Lymphopenia (HP:0001888) | 1.95928967 |
| 86 | Fatigue (HP:0012378) | 1.94605671 |
| 87 | Limb-girdle muscle atrophy (HP:0003797) | 1.94363807 |
| 88 | Episodic fever (HP:0001954) | 1.93857097 |
| 89 | Abnormality of T cells (HP:0002843) | 1.93726691 |
| 90 | Colitis (HP:0002583) | 1.93609287 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 1.93579001 |
| 92 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92291562 |
| 93 | Osteomyelitis (HP:0002754) | 1.92167773 |
| 94 | Gingival bleeding (HP:0000225) | 1.91480680 |
| 95 | Diminished motivation (HP:0000745) | 1.91462487 |
| 96 | Increased IgE level (HP:0003212) | 1.91138676 |
| 97 | Global brain atrophy (HP:0002283) | 1.90567392 |
| 98 | Frequent falls (HP:0002359) | 1.88610587 |
| 99 | Anorexia (HP:0002039) | 1.88482824 |
| 100 | Apathy (HP:0000741) | 1.86467721 |
| 101 | Cerebral aneurysm (HP:0004944) | 1.86033225 |
| 102 | Myoglobinuria (HP:0002913) | 1.85055277 |
| 103 | Thoracic kyphosis (HP:0002942) | 1.84826508 |
| 104 | Epistaxis (HP:0000421) | 1.84821955 |
| 105 | Hypochromic anemia (HP:0001931) | 1.84723860 |
| 106 | Sepsis (HP:0100806) | 1.84434020 |
| 107 | Bundle branch block (HP:0011710) | 1.82578971 |
| 108 | Cholecystitis (HP:0001082) | 1.81437774 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 1.81437774 |
| 110 | Mutism (HP:0002300) | 1.81265784 |
| 111 | Leukocytosis (HP:0001974) | 1.81025340 |
| 112 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80891029 |
| 113 | Vertebral compression fractures (HP:0002953) | 1.80113046 |
| 114 | Distal upper limb amyotrophy (HP:0007149) | 1.79122404 |
| 115 | Upper limb amyotrophy (HP:0009129) | 1.79122404 |
| 116 | Pulmonary embolism (HP:0002204) | 1.79015208 |
| 117 | Myopathic facies (HP:0002058) | 1.78870190 |
| 118 | Splenomegaly (HP:0001744) | 1.77459219 |
| 119 | Pulmonary infiltrates (HP:0002113) | 1.77106566 |
| 120 | Pustule (HP:0200039) | 1.76881869 |
| 121 | Gastrointestinal infarctions (HP:0005244) | 1.75018868 |
| 122 | Abnormal platelet function (HP:0011869) | 1.73437712 |
| 123 | Impaired platelet aggregation (HP:0003540) | 1.73437712 |
| 124 | Stomatitis (HP:0010280) | 1.73026557 |
| 125 | Dementia (HP:0000726) | 1.72718301 |
| 126 | Verrucae (HP:0200043) | 1.70998544 |
| 127 | Papilloma (HP:0012740) | 1.70998544 |
| 128 | Xanthomatosis (HP:0000991) | 1.70636619 |
| 129 | Increased serum ferritin (HP:0003281) | 1.70348379 |
| 130 | Exercise-induced muscle cramps (HP:0003710) | 1.69971939 |
| 131 | Meningitis (HP:0001287) | 1.69750486 |
| 132 | Vasculitis (HP:0002633) | 1.69351863 |
| 133 | Mitral stenosis (HP:0001718) | 1.68507549 |
| 134 | Hypergammaglobulinemia (HP:0010702) | 1.67894520 |
| 135 | Recurrent viral infections (HP:0004429) | 1.67704414 |
| 136 | Papilledema (HP:0001085) | 1.66021606 |
| 137 | Prolonged bleeding time (HP:0003010) | 1.66018564 |
| 138 | J-shaped sella turcica (HP:0002680) | 1.62407385 |
| 139 | Ankle clonus (HP:0011448) | 1.61126815 |
| 140 | Focal motor seizures (HP:0011153) | 1.60889033 |
| 141 | Neuronal loss in central nervous system (HP:0002529) | 1.60195203 |
| 142 | Hematochezia (HP:0002573) | 1.59671891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.34774177 |
| 2 | RIPK4 | 3.26366148 |
| 3 | ERN1 | 3.10204175 |
| 4 | MAP3K9 | 2.89706353 |
| 5 | KSR2 | 2.72365041 |
| 6 | SMG1 | 2.60685191 |
| 7 | PKN2 | 2.48033439 |
| 8 | MAP4K1 | 2.44954968 |
| 9 | PRPF4B | 2.43079697 |
| 10 | ARAF | 2.15206730 |
| 11 | IRAK3 | 2.08914797 |
| 12 | CAMKK2 | 2.06406865 |
| 13 | MAP3K13 | 2.00067587 |
| 14 | IRAK4 | 1.97221347 |
| 15 | TBK1 | 1.93181550 |
| 16 | FES | 1.83527361 |
| 17 | EPHB1 | 1.79051946 |
| 18 | CAMKK1 | 1.75903148 |
| 19 | NME2 | 1.74913644 |
| 20 | TAOK2 | 1.69657507 |
| 21 | GRK6 | 1.57357561 |
| 22 | MAP3K3 | 1.55416210 |
| 23 | VRK2 | 1.54481420 |
| 24 | TAOK1 | 1.47059657 |
| 25 | MAP2K3 | 1.44766598 |
| 26 | RAF1 | 1.43765572 |
| 27 | NTRK1 | 1.42042550 |
| 28 | BLK | 1.39106548 |
| 29 | MAP3K1 | 1.37931102 |
| 30 | TYK2 | 1.37490032 |
| 31 | RIPK1 | 1.33885032 |
| 32 | SYK | 1.31888613 |
| 33 | MAP3K12 | 1.29188801 |
| 34 | TTN | 1.28780062 |
| 35 | PAK6 | 1.27715654 |
| 36 | MAP3K11 | 1.26694096 |
| 37 | SIK1 | 1.19592773 |
| 38 | PDK1 | 1.18074757 |
| 39 | JAK3 | 1.17737288 |
| 40 | PDPK1 | 1.17687370 |
| 41 | LRRK2 | 1.16649396 |
| 42 | KDR | 1.12478087 |
| 43 | CDK19 | 1.12236362 |
| 44 | BTK | 1.11924178 |
| 45 | GRK5 | 1.10791587 |
| 46 | FGR | 1.10164539 |
| 47 | ZAP70 | 1.08431642 |
| 48 | KIT | 1.06238803 |
| 49 | SIK3 | 1.06019790 |
| 50 | EEF2K | 1.03886934 |
| 51 | TNK2 | 1.03214075 |
| 52 | HCK | 1.02451183 |
| 53 | JAK2 | 1.00717353 |
| 54 | MUSK | 0.97925153 |
| 55 | MST1R | 0.96410336 |
| 56 | LYN | 0.94501506 |
| 57 | IRAK2 | 0.93197317 |
| 58 | JAK1 | 0.91550558 |
| 59 | CSK | 0.91503274 |
| 60 | PIM2 | 0.90251517 |
| 61 | PRKD2 | 0.89320542 |
| 62 | ICK | 0.88826214 |
| 63 | MATK | 0.88609785 |
| 64 | RPS6KA2 | 0.87628505 |
| 65 | RET | 0.86631534 |
| 66 | SIK2 | 0.85267834 |
| 67 | TESK2 | 0.83168454 |
| 68 | MAP2K4 | 0.83117940 |
| 69 | DYRK1B | 0.81192091 |
| 70 | MAP3K7 | 0.79804128 |
| 71 | BMX | 0.78521954 |
| 72 | MAPK11 | 0.77381969 |
| 73 | FGFR4 | 0.77140464 |
| 74 | MAP3K10 | 0.75885930 |
| 75 | SCYL2 | 0.75861284 |
| 76 | MAP3K5 | 0.72683153 |
| 77 | LCK | 0.72552160 |
| 78 | MINK1 | 0.72284220 |
| 79 | MOS | 0.71989375 |
| 80 | MAP3K6 | 0.71773925 |
| 81 | CSF1R | 0.71070192 |
| 82 | KSR1 | 0.70970117 |
| 83 | TGFBR2 | 0.70806645 |
| 84 | MARK2 | 0.70630370 |
| 85 | TXK | 0.70590896 |
| 86 | IKBKB | 0.70307424 |
| 87 | ABL2 | 0.69678652 |
| 88 | ALK | 0.69631710 |
| 89 | LMTK2 | 0.68638947 |
| 90 | PTK2B | 0.68592632 |
| 91 | MAP3K4 | 0.68078655 |
| 92 | PTK6 | 0.66148400 |
| 93 | STK11 | 0.65903459 |
| 94 | TAOK3 | 0.64674346 |
| 95 | PRKG2 | 0.64186541 |
| 96 | FLT3 | 0.63657076 |
| 97 | MAPK12 | 0.62959735 |
| 98 | DAPK3 | 0.62286415 |
| 99 | CAMK1D | 0.61767815 |
| 100 | MAP3K2 | 0.61751128 |
| 101 | IKBKE | 0.60971256 |
| 102 | MARK3 | 0.60717436 |
| 103 | MAP2K1 | 0.60513905 |
| 104 | RPS6KC1 | 0.59213932 |
| 105 | RPS6KL1 | 0.59213932 |
| 106 | PHKG2 | 0.58972113 |
| 107 | PHKG1 | 0.58972113 |
| 108 | NTRK3 | 0.57896171 |
| 109 | DAPK2 | 0.57796945 |
| 110 | MAPK4 | 0.57483033 |
| 111 | MAP4K2 | 0.56432585 |
| 112 | ITK | 0.56183514 |
| 113 | MAP2K2 | 0.55685122 |
| 114 | HIPK2 | 0.55585484 |
| 115 | PIM1 | 0.52321832 |
| 116 | RPS6KA4 | 0.50910856 |
| 117 | PTK2 | 0.50514162 |
| 118 | PRKCH | 0.49262154 |
| 119 | PAK4 | 0.49216979 |
| 120 | STK10 | 0.48577006 |
| 121 | CAMK1G | 0.48129942 |
| 122 | BCKDK | 0.47561821 |
| 123 | CAMK1 | 0.47193844 |
| 124 | MAP3K14 | 0.45464004 |
| 125 | MAPKAPK3 | 0.45359629 |
| 126 | DAPK1 | 0.44931469 |
| 127 | TEC | 0.44885458 |
| 128 | DMPK | 0.44603798 |
| 129 | TESK1 | 0.42928050 |
| 130 | RPS6KA6 | 0.42631842 |
| 131 | DYRK3 | 0.42465855 |
| 132 | CDK4 | 0.42385321 |
| 133 | EPHA4 | 0.42061861 |
| 134 | ILK | 0.41997621 |
| 135 | PRKD3 | 0.40627153 |
| 136 | PRKD1 | 0.40290997 |
| 137 | IRAK1 | 0.39734951 |
| 138 | CDC42BPA | 0.37449265 |
| 139 | MAPKAPK2 | 0.36606301 |
| 140 | FYN | 0.35512476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.38193451 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.20949310 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.19198504 |
| 4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.14448377 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.12527412 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.11611274 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01565221 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95174748 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.87206591 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.84776778 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.84574418 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74692422 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74516118 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.72068600 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69829715 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.67000117 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61446892 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.51025974 |
| 19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.48991720 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46658262 |
| 21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.43540414 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43066804 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.41225896 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.40022951 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39784092 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.28851697 |
| 27 | Salmonella infection_Homo sapiens_hsa05132 | 1.27357928 |
| 28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.26592215 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25350976 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25255262 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.23734440 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22847777 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.22819841 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22009071 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21035932 |
| 36 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.17267985 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14294057 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13837114 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11773005 |
| 40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11403114 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.10615061 |
| 42 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.07429016 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05552444 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03713419 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.03267878 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02137377 |
| 47 | Salivary secretion_Homo sapiens_hsa04970 | 1.01203885 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01109295 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99972111 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98402857 |
| 51 | Insulin resistance_Homo sapiens_hsa04931 | 0.97001031 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 0.95016659 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.93470919 |
| 54 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92274647 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91579375 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91504096 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89979680 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87614270 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87558571 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 0.86753091 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86393725 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86357935 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.85501951 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83737217 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83657618 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.82787140 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82653912 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.81630249 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.80499409 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80199243 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79899428 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78271362 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.78164379 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78146752 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78098180 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77230421 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76861246 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76418411 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.76211220 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75634841 |
| 81 | Legionellosis_Homo sapiens_hsa05134 | 0.75512295 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75229729 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.75098639 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74896115 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.73988067 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73465381 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73113009 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72939665 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.72657197 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71886731 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71881029 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71303826 |
| 93 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70167182 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67973016 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.67533145 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66913223 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66671149 |
| 98 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66382319 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.66300158 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.65830747 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64881908 |
| 102 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64582118 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64406437 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64032803 |
| 105 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62605242 |
| 106 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62151104 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61951561 |
| 108 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61546225 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61448858 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60874759 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60567256 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60515232 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.58804853 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58803527 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58784153 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58341637 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58202067 |
| 118 | Morphine addiction_Homo sapiens_hsa05032 | 0.57974522 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57669141 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57555514 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57536074 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.55609250 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55572160 |
| 124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54242295 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52413229 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51381092 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51215341 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51160698 |
| 129 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51001942 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49578994 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48457449 |
| 132 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48365094 |
| 133 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.47715640 |
| 134 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47514321 |
| 135 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46447608 |
| 136 | Measles_Homo sapiens_hsa05162 | 0.45864566 |
| 137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45609142 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42822541 |
| 139 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42734169 |
| 140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40060281 |
| 141 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39450217 |

